People In Brief: Soller consults, Sharaf joins AHPA, Perrigo hires Crabill, Villaraigosa advises Herbalife
This article was originally published in The Tan Sheet
Soller leaves UCSF to consult full-time; Aker hires former Clavis Pharma scientists for krill R&D; Perrigo adds nutritional regulatory manager; USP veteran Sharaf joins AHPA; ex-mayor of Los Angeles advises Herbalife; FDA’s Plaisier earns permanent ORA appointment; more People In Brief.
You may also be interested in...
The reorganized ORA has eight new offices to better handle new legislative authorities and globalization of its regulated products; FDA expects to increase partnerships with other government officials and foreign entities.
Just three years after its founding, Chinese cell therapy developer IASO Bio already has two assets in clinical development and the Nanjing firm has recently attracted $60m in financing. In an exclusive interview, its R&D head told Scrip that speed and partnerships are propelling Chinese developers on a trajectory to quickly catch up with the west in the emerging cell-therapy arena.
Updated guidance from England’s National Institute for Health and Care Excellence says two neurostimulation systems for treatment-resistant depression and epilepsy should only be used under special conditions. See what LivaNova’s VP of difficult-to-treat depression, Jonathan Walker, said about it here.